Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUltrasis Plc Regulatory News (ULT)

  • There is currently no data for ULT

Statement re new distribution

4 Jun 2008 07:00

RNS Number : 7858V
Ultrasis PLC
04 June 2008
 



Ultrasis plc

Beating the Blues now available for private patients

Ultrasis meets growing private demand for access to anxiety and depression therapy

Ultrasis plc, the provider of interactive healthcare and associated services, is pleased to announce the launch of Beating the Blues Connect. Beating the Blues Connect will combine on-line therapy with 24/7 telephonic support, to meet the growing demand from private patients for confidential and immediate access to treatment for mild and moderate depression and anxiety related problems.  The initial price of Beating the Blues Connect, which includes 16 weeks telephonic support and one year's access to Beating the Blues will be £325.00.

An estimated six million people suffer from anxiety and depression in the UK and evidence indicates that in excess of 25% of people with mental health problems do not go to their GP or the NHS for supportoften to preserve confidentialityIn response, Ultrasis is making its flagship Beating the Blues programme available for private use.

Beating the Blues Connect will be delivered by LTL Connect which will provide the service through its dedicated 24 hour call centre in Cardiff. LTL Connect is renowned for delivering wellbeing services on behalf of the Teacher Support Network to over 800,000 Teachers and Educational Staff in the UK and for its involvement in the Welsh 'Healthy Minds at Work' programme.

 

Nigel Brabbins, Ultrasis' Chief Executivesaid: 

"Since the National Institute for Health and Clinical Excellence recommended Beating the Blues for use across the NHS there has been a rising tide of demand from private patients. It's widely known that many people don't want to go to traditional services to receive support, many choosing to pay reasonable price for convenience, ease of access and confidentiality. Beating the Blues Connect will meet this demand, providing a high quality, evidence based way of helping people to recover their emotional well-being. The price for this cutting edge product is highly competitive.

He added: "The partnership we have developed with LTL Connect to deliver this retail version will also enable us to look at opportunities to deliver bespoke packages into the workplace, enabling employers to address mental health issues as part of their duty of care

"The launch of Beating the Blues Connect, as heralded in the recent interim statement, creates another opportunity to extend sales activity beyond the NHS, where Ultrasis continues to experience high renewal rates, sustained income growth and increased market penetration."

Patrick Nash, LTL Connect Chief Executive said:

"With more and more people experiencing depression and limited availability of therapy, Beating the Blues Connect is an effective, supported way people can get help and feel better. It not only represents good value, but there are no waiting lists, it removes any stigma and puts people in control of their own treatment plan. LTL Connect has significant experience in supporting and counselling people with a range of common mental heath problems and will provide reliable support to people using Beating the Blues Connect."

To find out more about Beating the Blues Connect, visit, www.thewellnessshop.co.uk

- ends -

For further information please contact:

Ultrasis plc:

Nigel Brabbins, Chief Executive

+44 (0) 20 7566 3900

nbrabbins@ultrasis.com

www.ultrasis.com

FinnCap, NOMAD and Joint Broker

Geoff Nash

+44 (0) 20 7600 1658

Notes to editors:

About Ultrasis plc

Cognitive Behavioural therapy (CBT) is the psychological treatment of choice for people suffering from anxiety and depression. NICE clinical guidelines for  anxiety and depression (published in Dec 2004) emphasised the importance of this therapy and at the same time recommended that sufferers from mild depression should not, initially, be given drugs but self-help material, preferably based on CBT, should be offered. 

In February 2006 The National Institute for Health & Clinical Excellence (NICE) recommended using Beating the Blues for delivering Cognitive Behavioural Therapy (CBTby computer in the management of mild and moderate depression. 

Beating the Blues is an eight-week, web-based treatment programme for depression based on Cognitive Behavioural Therapy. Following a rigorous examination by the National Institute for Health and Clinical Excellence (NICE), 

Seven out of Ten patients suffering from depression who used Beating the Blues® required no further treatment. Waiting lists for face to face therapy extend to 18 months in some areas. 

Ultrasis was the first company to offer computerised products based on Cognitive Behavioural Therapy (CBT) and interactive multimedia, and is the world leader in the field. The products help people tackle stress, anxiety and depression, and a full spectrum of related chronic conditions.

www.ultrasis.com 

www.thewellnessshop.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STREAKKAEELPEFE
Date   Source Headline
11th Jun 201512:00 pmRNSResignation of NOMAD
2nd Jun 201512:16 pmRNSScreenetics UK Ltd placed into administration
13th May 20159:00 amRNSNotice of contract termination
22nd Apr 20151:30 pmRNSNotice of intention to appoint Administrators
17th Apr 20158:00 amRNSProposed Fundraising not proceeding
8th Apr 20153:15 pmRNSUpdate regarding General Meeting
31st Mar 20158:24 amRNSSuspension of trading in the Company's shares
31st Mar 20157:45 amRNSSuspension - Ultrasis Plc
17th Mar 20157:00 amRNSDispatch of Circular, Notice of GM and AGM
2nd Mar 20157:00 amRNSRe: Proposed Refinancing
30th Jan 20154:30 pmRNSResults for the year ended 31 July 2014
15th Dec 20147:00 amRNSProposed Refinancing
12th Dec 20148:27 amRNSStmnt re Share Price Movement
3rd Dec 20147:00 amRNSUpdate on financial position
23rd Oct 20147:00 amRNSDirectorate Change
20th Oct 201412:35 pmRNSFinancing update
7th Oct 20147:00 amRNSBoard Changes and Financing Update
29th Sep 20147:00 amRNSPartnership to launch health screening program
8th Sep 201412:15 pmRNSHolding(s) in Company
19th Aug 20147:00 amRNSTrading statement
22nd Jul 20147:00 amRNSContract win
18th Jul 20147:00 amRNSLaunch of 'My Health Coach' App
22nd May 201411:49 amRNSAcquisition of Shares by a Director under SIP
14th May 20147:00 amRNSDirectorate Change
7th May 20147:00 amRNSDirectorate Change
30th Apr 20147:00 amRNSInterim Results
18th Mar 20147:00 amRNSSuccessful VA "peer supported pilot project"
4th Mar 20149:40 amRNSReplacement re: contract win
4th Mar 20147:00 amRNSPublic sector contract win and additional funding
14th Feb 20147:00 amRNSDirector dealing & Block Listing 6 Monthly Update
4th Feb 201411:57 amRNSContract win
30th Jan 20144:00 pmRNSResult of AGM
30th Jan 201412:00 pmRNSAcquisition of Occupational Health Business
22nd Jan 20147:00 amRNSNew BTB 2.0 Application Launched in the U.S.
15th Jan 20147:00 amRNSUltrasis announce 3year contract for Step Success
14th Jan 20147:00 amRNSNew Customer for Ultrasis US Joint Venture
6th Jan 20145:35 pmRNSAnnual Report & Notice of AGM
3rd Jan 20147:00 amRNSDr John Martin to Retire in June 2014
27th Dec 201310:50 amRNSIssue of Equity
20th Dec 20137:00 amRNSNew Tool from U Squared Interactive
10th Dec 20137:01 amRNSThree year Partnership for "Step Success"
10th Dec 20137:00 amRNSResults for the year ended 31 July 2013
28th Nov 20139:30 amRNSUltrasis launch Ki Group in partnership with NHS
19th Nov 20137:00 amRNSAcquisition of Step Success
18th Nov 20137:00 amRNSScreenetics contract win
4th Nov 20132:45 pmRNSIssue of Shares under Share Incentive
4th Nov 20137:00 amRNSContract with CiMH
31st Oct 20137:00 amRNSContract with MHASP
14th Oct 20138:30 amRNSIssue of Equity
4th Oct 20134:10 pmRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.